Menarini Stemline

With over 2.3 million new cases in 2020, breast cancer is the most diagnosed cancer in women worldwide. As the month comes to a close, we continue to shine a light on breast cancer, and remain committed to the breast cancer community, all year long. #BreastCancerAwarenessMonth

Yesterday the Menarini Stemline team joined thousands of members of the breast cancer community for a walk around Central Park in New York City! We were proud to be a sponsor of the American Cancer Society’s Making Strides Against Breast Cancer walk, and be a part of this incredible movement that provides a supportive community for breast cancer survivors and thrivers, as well as for their caregivers, friends, and families. #BreastCancerAwarenessMonth

Nearly 30% of women diagnosed with early-stage breast cancer develop metastatic disease, which is when the cancer can come back in another part of the body months or years after the original diagnosis. Today, Metastatic Breast Cancer Awareness Day, serves as a crucial reminder of why our Menarini Stemline team remains driven to find new options for the individuals living with metastatic breast cancer. #BreastCancerAwarenessMonth

Did you know that breast cancer represents 25% of all cancers in women? At Menarini Stemline we are proud to continue to raise awareness, and support the individuals and families impacted by breast cancer. #BreastCancerAwarenessMonth

We are delighted to announce our win for the PM360 2024 Trailblazer Award for our ESR1 metastatic breast cancer educational campaign. Thank you to PM360 Magazine for this honor!

Today marks the start of Breast Cancer Awareness Month. At Menarini Stemline, we are committed to improving the outcomes for those impacted by breast cancer, the most commonly diagnosed cancer in women worldwide. #BreastCancerAwarenessMonth

Rare cancer diagnoses account for about 25% of all cancer diagnoses. This #RareCancer Day learn more about BPDCN, a rare, aggressive hematologic malignancy: BPDCNinfo.com

As we continue to recognize Blood Cancer Awareness Month, we are shining a light on BPDCN, an aggressive hematologic malignancy. Learn more at BPDCNinfo.com.

This past weekend our colleagues participated in City of Hope’s Walk for Hope! We are proud to support City of Hope’s efforts to fund lifesaving research, access-widening advocacy, and dignity-giving care for all.

Our team is heading to Barcelona this week to connect with the global oncology community at #ESMO24! Be sure to visit our booth to learn more about Menarini Stemline’s focus on bringing transformational oncology treatments to people living with cancer.